Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD80 (Galiximab Biosimilar) anticorps

Cet anticorps Human Monoclonal détecte spécifiquement CD80 (Galiximab Biosimilar) dans BR, ELISA, FACS, IHC, IP et WB. Il présente une réactivité envers Humain.
N° du produit ABIN7072387

Aperçu rapide pour Recombinant CD80 (Galiximab Biosimilar) anticorps (ABIN7072387)

Antigène

CD80 (Galiximab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 1
  • 1
  • 1
Human

Clonalité

  • 2
  • 1
Monoclonal

Conjugué

  • 3
Cet anticorp CD80 (Galiximab Biosimilar) est non-conjugé

Application

Blocking Reagent (BR), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB)

Clone

IDEC-114
  • Fonction

    Anti-CD80 [IDEC-114 (Galiximab)], Human IgG1, lambda

    Specificité

    Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80. CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells, and expressed consitutively on various subtypes of B-cell lymphomas.

    Attributs du produit

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013)

    Isotype

    IgG1 lambda
  • Indications d'application

    Galiximab acts to decrease in cell proliferation, inhibition of the constitutively active NF-κB pathway, increase in apoptosis and ADCC against various B-cell lymphoma cell lines. Galiximb affects CD28 and CD152 interactions with CD80. This antibody can also be used for FC, WB, ELISA, IP and IHC.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CD80 (Galiximab Biosimilar)

    Classe de substances

    Biosimilar

    Sujet

    B7-1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7

    UniProt

    P33681
Vous êtes ici:
Chat with us!